XML 64 R48.htm IDEA: XBRL DOCUMENT v3.6.0.2
Related Party Transactions - Additional Information (Detail) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 8 Months Ended 12 Months Ended
May 31, 2016
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2014
Dec. 31, 2016
Dec. 31, 2015
Aug. 31, 2015
Jul. 31, 2014
Related Party Transaction [Line Items]                            
Research and development expense related to license and service agreements with related party   $ 11,331 $ 7,861 $ 7,423 $ 5,225 $ 4,375 $ 3,458 $ 1,966 $ 1,371 $ 1,105 $ 31,840 $ 11,170    
General and administrative expenses   5,118 4,705 3,729 3,246 2,809 1,531 2,833 1,110 2,379 16,798 8,283    
Collaboration revenue   $ 5,627 $ 4,869 $ 4,206 $ 1,777 1,693 $ 1,688 $ 1,377 $ 1,286   $ 16,479 $ 6,044    
Class A-2 Preferred Units [Member]                            
Related Party Transaction [Line Items]                            
Common stock, shares acquired                       1,333,333    
Caribou [Member]                            
Related Party Transaction [Line Items]                            
Junior preferred units issued                           8,110,599
Percentage of shares owned   15.50%                 15.50%      
Research and development expense related to license and service agreements with related party                   200 $ 1,300 $ 1,500    
Current obligations related to license and service agreements with related party           600           600    
General and administrative expenses                   200 $ 900 $ 1,100    
Percentage of related party obligation                     30.00% 30.00%    
Caribou [Member] | In Process Research and Development [Member]                            
Related Party Transaction [Line Items]                            
Research and development expense related to license and service agreements with related party                   $ 6,100        
Novartis [Member] | Collaborative Arrangement [Member]                            
Related Party Transaction [Line Items]                            
Percentage of shares owned   15.50%                 15.50%      
Common stock, shares acquired 277,777                          
Collaboration revenue                     $ 7,800 $ 6,000    
Accounts receivable   $ 6,000       1,000         6,000 1,000    
Deferred revenue   $ 11,600       $ 10,300         $ 11,600 $ 10,300    
Novartis [Member] | Class A-1 Preferred Units [Member] | Collaborative Arrangement [Member]                            
Related Party Transaction [Line Items]                            
Junior preferred units issued           4,761,905           4,761,905    
Novartis [Member] | Class A-2 Preferred Units [Member] | Collaborative Arrangement [Member]                            
Related Party Transaction [Line Items]                            
Junior preferred units issued           2,666,666           2,666,666    
Novartis [Member] | Series B Preferred Stock [Member] | Collaborative Arrangement [Member]                            
Related Party Transaction [Line Items]                            
Preferred stock, shares acquired                         761,905